Clinical Trial Update: Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating orally administered MOMA-313 in adults with advanced or metastatic solid tumors; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• MOMA-313

Snippet

Sponsor: MOMA Therapeutics | Conditions: Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING